LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing sidepopulation stem-like cancer cells

Oncotarget

Volumn 7, Issue 38, 2016, Pages 61741-61754

  Zou, Zhen Wei ^a   Ma, Charlie ^b   Medoro, Lorraine ^b   Chen, Lili ^b   Wang, Bin ^b   Gupta, Roohi ^b   Liu, Ting ^a   Yang, Xian Zi ^c   Chen, Tian Tian ^c   Wang, Ruo Zhen ^d   Zhang, Wen Jie ^e   Li, Pin Dong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b FOX CHASE CANCER CENTER   (United States)

^c SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^d XINJIANG MEDICAL UNIVERSITY   (China)

^e SHIHEZI UNIVERSITY   (China)

Author keywords

Carcinoma; Glucose metabolism; LncRNA ANRIL; MTOR pathway; Nasopharyngeal

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLUCOSE TRANSPORTER 1; LACTATE DEHYDROGENASE; LONG UNTRANSLATED RNA; LONG UNTRANSLATED RNA ANRIL; MAMMALIAN TARGET OF RAPAMYCIN; UNCLASSIFIED DRUG; ANRIL LONG NON-CODING RNA, HUMAN; ANTISENSE OLIGONUCLEOTIDE; GLUCOSE; TUMOR MARKER;

ADULT; ADVANCED CANCER; AGED; ANRIL GENE; ARTICLE; CANCER CELL; CANCER CLASSIFICATION; CANCER GROWTH; CANCER RECURRENCE; CANCER STAGING; CELL PROLIFERATION; CELL REPROGRAMMING TECHNIQUE; CELL TRANSFORMATION; CLONOGENESIS; COHORT ANALYSIS; COLONY FORMATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; EXON; FEMALE; GENE CLUSTER; GENE EXPRESSION REGULATION; GENE SILENCING; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOLYSIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; OVERALL SURVIVAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIDE POPULATION CELL; SIGNAL TRANSDUCTION; UPREGULATION; CANCER STEM CELL; CARCINOMA; CYTOLOGY; DISEASE EXACERBATION; GENETICS; METABOLISM; MIDDLE AGED; MULTIGENE FAMILY; MULTIVARIATE ANALYSIS; NASOPHARYNX TUMOR; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUCOSE; GLYCOLYSIS; HUMANS; MIDDLE AGED; MULTIGENE FAMILY; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASTIC STEM CELLS; OLIGONUCLEOTIDES, ANTISENSE; RNA, LONG NONCODING; SIDE-POPULATION CELLS; TREATMENT OUTCOME; UP-REGULATION; YOUNG ADULT;

EID: 84991832912     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.11437     Document Type: Article

References (52)

1. Tano KN. Akimitsu. Long non-coding RNAs in cancer progression. Front Genet. 2012; 3:219.
2. Chan AT, Teo PM, Johnson PJ. Nasopharyngeal carcinoma. Ann Oncol. 2002; 13:1007-15.
3. Huang DP, Johnson PJ, Huang DP, Johnson PJ. Introduction: nasopharyngeal cancer. Semin Cancer Biol. 2002; 12:419.
4. Lo KW, Chung TY, To KF. Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches. Semin Cancer Biol. 2012; 22:79-86.
5. Wei X, Zhao YZ, Jia HX, Xia K, Shou RS, Xiao LL, Dong XH, Chen T, Xiang JJ, Jie Z. A susceptibility locus at chromosome 3p21 linked to familial nasopharyngeal carcinoma. Cancer Res. 2004; 64:1972-4.
6. Zeng ZY, Huang HB, Huang LL, Sun MX, Yan QJ, Song YL, Fang W, Hao B, Gong ZJ, Yong Z. Regulation network and expression profiles of Epstein-Barr virusencoded microRNAs and their potential target host genes in nasopharyngeal carcinomas. Sci China Life Sci. 2014; 57:315-326.
7. Zeng Z, Zhou Y, Zhang W, Li X, Xiong W, Liu H, Fan S, Qian J, Wang L, Li Z. Family-based association analysis validates chromosome 3p21 as a putative nasopharyngeal carcinoma susceptibility locus. Genet Med. 2006; 8:156-60.
8. Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell. 2004; 5:423-8.
9. Tang LQ, Chen QY, Guo SS, Chen WH, Li CF, Zhang L, Lai XP, He Y, Xu YX, Hu DP. The impact of plasma Epstein-Barr virus DNA and fibrinogen on nasopharyngeal carcinoma prognosis: an observational study. Br J Cancer. 2014; 111:1102-1111.
10. Sun D, Yang Z, Fu Y, Chen Y, Wang S, Zhang Y, Ma Y, Zhang X. Clinical value of serum Epstein-Barr virus DNA assay in the diagnosis of nasopharyngeal carcinoma. Tumour Biol. 2014; 35:8787-93.
11. Gutschner TS. Diederichs, The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 2012; 9:703-19.
12. Gong ZJ, Zhang SS, Zhang WL, Huang HB, Qiao L, Hao D, Jian M, Ming Z, Xiang JJ, Wu MH. Long non-coding RNAs in cancer. Sci China Life Sci. 2012; 55:1120-1124.
13. Chen XM, Zhang DD, Luo JJC, RS. Research Progress on Long Noncoding RNAs. Prog Biochem biophys. 2014; 41:997-1009.
14. Meryet-Figuiere M, Lambert B, Gauduchon P, Vigneron N, Brotin E, Poulain L, Denoyelle C. An overview of long noncoding RNAs in ovarian cancers. Oncotarget. 2016; doi: 10.18632/oncotarget.8089.
15. Pasmant E, Laurendeau I, Heron D, Vidaud M, Vidaud D, Bieche I. Characterization of a Germ-Line Deletion, Including the Entire INK4/ARF Locus, in a Melanoma-Neural System Tumor Family: Identification of ANRIL, an Antisense Noncoding RNA Whose Expression Coclusters with ARF. Cancer Res. 2007; 67:3963-3969.
16. Zhang EB, Kong R, Yin DD, You LH, Sun M, Han L, Xu TP, Xia R, Yang JS, De W. Long noncoding RNA ANRIL indicates a poor prognosis of gastric cancer and promotes tumor growth by epigenetically silencing of miR-99a/miR-449a. Oncotarget. 2014; 5:2276-92. doi: 10.18632/oncotarget.1902.
17. Iranpour M, Soudyab M, Geranpayeh L, Mirfakhraie R, Azargashb E, Movafagh A Ghafouri-Fard S. Expression analysis of four long noncoding RNAs in breast cancer. Tumour Biol. 2016; 37:2933-40.
18. Zhu H, Li X, Song Y, Zhang P, Xiao Y, Xing Y. Long noncoding RNA ANRIL is up-regulated in bladder cancer and regulates bladder cancer cell proliferation and apoptosis through the intrinsic pathway. Biochem Biophys Res Commun. 2015; 467:223-8.
19. Naemura M, Murasaki C, Inoue Y, Okamoto H, Kotake Y. Long Noncoding RNA ANRIL Regulates Proliferation of Non-small Cell Lung Cancer and Cervical Cancer Cells. Anticancer Res. 2015; 35:5377-82.
20. Aguilo F, Zhou MM, Walsh MJ. Long noncoding RNA, polycomb, and the ghosts haunting INK4b-ARF-INK4a expression. Cancer Res. 2011; 71:5365-9.
21. Naemura M, Tsunoda T, Inoue Y, Okamoto H, Shirasawa S, Kotake Y. ANRIL regulates the proliferation of human colorectal cancer cells in both two-and three-dimensional culture. Mol Cell Biochem. 2015; 111:1-6.
22. Chen RH, Du Y, Han P, Wang HB, Liang FY, Feng GK, Zhou AJ, Cai MY, Zhong Q, Zeng MS, Huang XM. ISG15 predicts poor prognosis and promotes cancer stem cell phenotype in nasopharyngeal carcinoma. Oncotarget. 2016; 7:16910-22. doi: 10.18632/oncotarget.7626.
23. Kong QL, Hu LJ, Cao JY, Huang YJ, Xu LH, Liang Y, Xiong D, Guan S, Guo BH, Mai HQ, Chen QY, Zhang X, Song, YX, et al. Epstein-Barr virus-encoded LMP2A induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathog. 2010; 6:e1000940.
24. Salerno M, Avnet S, Bonuccelli G, Eramo A, De Maria R, Gambarotti M, Gamberi G, Baldini N. Sphere-forming cell subsets with cancer stem cell properties in human musculoskeletal sarcomas. Int J Oncol. 2013; 43:95-102.
25. Takubo K, Ohmura M, Azuma M, Nagamatsu G, Yamada W, Arai F, Hirao A, Suda T. Stem cell defects in ATMdeficient undifferentiated spermatogonia through DNA damage-induced cell-cycle arrest. Cell Stem Cell. 2008; 2:170-82.
26. Ninomiya T, Hiraga T, Hosoya A, Ohnuma K, Ito Y, Takahashi M, Ito S, Asashima M, Nakamura H. Enhanced bone-forming activity of side population cells in the periodontal ligament. Cell Transplant. 2014; 23:691-701.
27. Hanahan DR. Weinberg, Hallmarks of Cancer: The Next Generation. Cell. 2011; 144:646-74.
28. Zou C, Wang Y, Shen Z. 2-NBDG as a fluorescent indicator for direct glucose uptake measurement. J Biochem Biophys Methods. 2005; 64:207-15.
29. Schulze AAL. Harris, How cancer metabolism is tuned for proliferation and vulnerable to disruption. Nature. 2012; 491:364-373.
30. Furuta E, Okuda H, Kobayashi A, Watabe K. Metabolic genes in cancer: Their roles in tumor progression and clinical implications. Biochimica Et Biophysica Acta. 2010; 1805:141-152.
31. Jones NPA. Schulze, Targeting cancer metabolism-aiming at a tumour's sweet-spot. Drug Discov Today. 2012; 17:232-41.
32. Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol. 2011; 12:21-35.
33. Nie FQ, Sun M, Yang JS, Xie M, Xu TP, Xia R, Liu YW, Liu XH, Zhang EB, Lu KH. Long noncoding RNA ANRIL promotes non-small cell lung cancer cell proliferation and inhibits apoptosis by silencing KLF2 and P21 expression. Mol Cancer Ther. 2015; 14:268-77.
34. Hua L, Wang CY, Yao KH, Chen JT, Zhang JJ, Ma WL. High expression of long non-coding RNA ANRIL is associated with poor prognosis in hepatocellular carcinoma. Int J Clin Exp Pathol. 2015; 8:3076-82.
35. Kang YH, Kim D, Jin EJ. Down-regulation of Phospholipase D Stimulates Death of Lung Cancer Cells Involving Up-regulation of the Long ncRNA ANRIL. Anticancer Res. 2015; 35:2795-803.
36. Chen D, Zhang Z, Mao C, Zhou Y, Yu L, Yin Y, Wu S, Mou X, Zhu Y. ANRIL inhibits p15(INK4b) through the TGFβ1 signaling pathway in human esophageal squamous cell carcinoma. Cell Immunol. 2014; 289:91-96.
37. Qiu JJ, Lin YY, Ding JX, Feng WW, Jin HY, Hua KQ. Long non-coding RNA ANRIL predicts poor prognosis and promotes invasion/metastasis in serous ovarian cancer. Int J Oncol. 2015; 46:2497-2505.
38. Huang MD, Chen WM, Qi FZ, Sun, Xu TP, Ma P, Shu YQ. Long non-coding RNA TUG1 is up-regulated in hepatocellular carcinoma and promotes cell growth and apoptosis by epigenetically silencing of KLF2. Mol Cancer. 2015; 14:1-12.
39. Kotake Y, Nakagawa T, Kitagawa K, Suzuki S, Liu N, Kitagawa M, Xiong Y. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene. 2011; 30:1956-62.
40. Yap KL, Li S, Muñoz-Cabello AM, Raguz S, Zeng L, Mujtaba S, Gil J, Walsh MJ, Zhou MM. Molecular Interplay of the Noncoding RNA ANRIL and Methylated Histone H3 Lysine 27 by Polycomb CBX7 in Transcriptional Silencing of INK4a. Mol Cell. 2010; 38:662-674.
41. Li YJ. Laterra, Cancer stem cells: distinct entities or dynamically regulated phenotypes? Cancer Res. 2012; 72:576-80.
42. Morrison SJJ. Kimble, Asymmetric and symmetric stemcell divisions in development and cancer. Nature. 2006; 441:1068-74.
43. Pu H, Zheng Q, Li H, Wu M, An J, Gui X, Li T, Lu D. CUDR promotes liver cancer stem cell growth through upregulating TERT and C-Myc. Oncotarget. 2015; 6:40775-98. doi: 10.18632/oncotarget.5805.
44. Wang J, Guo LP, Chen LZ, Zeng YX, Lu SH, Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Res. 2007; 67:3716-24.
45. Yang CF, Peng LX, Huang TJ, Yang GD, Chu QQ, Liang YY, Cao X, Xie P, Zheng LS, Huang HB. Cancer stem-like cell characteristics induced by EB virus-encoded LMP1 contribute to radioresistance in nasopharyngeal carcinoma by suppressing the p53-mediated apoptosis pathway. Cancer Lett. 2014; 344:260-271.
46. Wang WJ, Wu SP, Liu JB, Shi YS, Huang X, Zhang QB, Yao KT. MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells. Cancer Res. 2013; 73:1219-1231.
47. Vander Heiden MG, Cantley LC, Thompson CB. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation. Science. 2009; 324:1029-1033.
48. DeBerardinis RJ, Lum JJ, Hatzivassiliou G, Thompson CB. The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab. 2008; 7:11-20.
49. Chang CH, Qiu J, O'Sullivan D, Buck MD, Noguchi T, Curtis JD, Chen Q, Gindin M, Gubin MM, van der Windt GJ, Tonc E, Schreiber RD, et al. Pearce, Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression. Cell. 2015; 162:1229-41.
50. Hung CL, Wang LY, Yu YL, Chen HW, Srivastava S, Petrovics G, Kung HJ. A long noncoding RNA connects c-Myc to tumor metabolism. Proc Natl Acad Sci USA. 2014; 111:18697-702.
51. Bochenek G, Hasler R, El Mokhtari NE, Konig IR, Loos BG, Jepsen S, Rosenstiel P, Schreiber S, Schaefer AS. The large non-coding RNA ANRIL, which is associated with atherosclerosis, periodontitis and several forms of cancer, regulates ADIPOR1, VAMP3 and C11ORF10. Hum Mol Genet. 2013; 22:4516-27.
52. Pasmant E, Sabbagh A, Masliahplanchon J, Ortonne N, Laurendeau I, Melin L, Ferkal S, Hernandez L, Leroy K, Valeyrieallanore L. Role of noncoding RNA ANRIL in genesis of plexiform neurofibromas in neurofibromatosis type 1. J Natl Cancer Inst. 2011; 103:1713-1722.